A detailed history of Bank Of America Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 987,850 shares of MRNA stock, worth $72.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
987,850
Previous 917,835 7.63%
Holding current value
$72.5 Million
Previous $97.8 Million 19.94%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $7.09 Million - $11.7 Million
70,015 Added 7.63%
987,850 $117 Million
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $13.6 Million - $18.4 Million
159,736 Added 21.07%
917,835 $97.8 Million
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $2 Million - $3.01 Million
-28,826 Reduced 3.66%
758,099 $75.4 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $20.4 Million - $27.7 Million
-172,372 Reduced 17.97%
786,925 $95.6 Million
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $50.7 Million - $73.6 Million
373,563 Added 63.78%
959,297 $147 Million
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $55.9 Million - $99.2 Million
-472,334 Reduced 44.64%
585,734 $105 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $25.9 Million - $42.6 Million
219,132 Added 26.12%
1,058,068 $125 Million
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $67.3 Million - $101 Million
-574,391 Reduced 40.64%
838,936 $120 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $33.2 Million - $61.6 Million
262,249 Added 22.78%
1,413,327 $243 Million
Q4 2021

Feb 08, 2022

BUY
$225.82 - $368.51 $79.5 Million - $130 Million
352,026 Added 44.06%
1,151,078 $292 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $24.1 Million - $52.6 Million
108,519 Added 15.72%
799,052 $308 Million
Q2 2021

Sep 13, 2021

BUY
$129.91 - $234.98 $89.7 Million - $162 Million
690,533 New
690,533 $162 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $28.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.